Antinociceptive effects of opioids following acute and chronic administration of butorphanol: influence of stimulus intensity and relative efficacy at the mu receptor
- PMID: 10353428
- DOI: 10.1007/s002130050945
Antinociceptive effects of opioids following acute and chronic administration of butorphanol: influence of stimulus intensity and relative efficacy at the mu receptor
Abstract
Rationale: A common treatment strategy for the management of severe pain involves the co-administration of multiple opioid analgesics. Due to the increasing popularity of this practice, it is becoming increasingly important to understand the interactions between clinically employed opioids under a wide range of conditions.
Objective: The purpose of the present investigation was to examine the effects of opioid combinations following acute and chronic administration of the low-efficacy mu-opioid butorphanol, and to determine if the effects of these combinations are modulated by the intensity of the nociceptive stimulus.
Methods: In a warm-water, tail-withdrawal procedure, rats were restrained and the latencies to remove their tails from 50 degrees C (low temperature) and 55 degrees C (high temperature) water were measured following both acute and chronic administration of butorphanol. Opioids possessing both high (etorphine, levorphanol, morphine) and low [dezocine, (-)-pentazocine, nalbuphine] relative efficacy at the mu receptor were examined.
Results: Under acute conditions, etorphine, levorphanol, morphine and dezocine increased tail-withdrawal latencies at both low and high temperatures, whereas (-)-pentazocine, nalbuphine and butorphanol increased latencies only at the low temperature. A dose of 30 mg/kg butorphanol increased the effects produced by these opioids at the low temperature, but antagonized the effects of etorphine, levorphanol, morphine and dezocine at the high temperature. During chronic treatment with 30 mg/kg per day butorphanol, tolerance was conferred to the antinociceptive effects of all the opioids examined, with greater degrees of tolerance conferred to those opioids possessing low efficacy at the mu receptor. During butorphanol treatment, etorphine, levorphanol and morphine increased tail-withdrawal latencies at both water temperatures, dezocine increased latencies at only the low temperature, and (-)-pentazocine, nalbuphine and butorphanol failed to increase latencies at either temperature. A dose of 30 mg/kg butorphanol antagonized the antinociceptive effects of etorphine, levorphanol, morphine and dezocine during chronic treatment, and these effects were observed at both water temperatures.
Conclusions: These findings indicate that the interactions between butorphanol and other mu opioids vary quantitatively between low and high stimulus intensities, and between acute and chronic conditions. In most instances, however, these interactions can be predicted from the effects of the drugs when administered alone.
Similar articles
-
An examination of the interactions between the antinociceptive effects of morphine and various mu-opioids: the role of intrinsic efficacy and stimulus intensity.Anesth Analg. 1999 Feb;88(2):407-13. doi: 10.1097/00000539-199902000-00035. Anesth Analg. 1999. PMID: 9972766
-
Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor.Psychopharmacology (Berl). 2000 Jul;150(4):430-42. doi: 10.1007/s002130000453. Psychopharmacology (Berl). 2000. PMID: 10958085
-
Age-related differences in sensitivity to the antinociceptive effects of opioids in male rats. Influence of nociceptive intensity and intrinsic efficacy at the mu receptor.Psychopharmacology (Berl). 2001 Aug;156(4):445-53. doi: 10.1007/s002130100750. Psychopharmacology (Berl). 2001. PMID: 11498722
-
Opioid agonist-antagonist drugs in acute and chronic pain states.Drugs. 1991 Mar;41(3):326-44. doi: 10.2165/00003495-199141030-00002. Drugs. 1991. PMID: 1711441 Review.
-
Opioids, Opioid Antagonists.2020 Nov 24. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2020 Nov 24. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643200 Free Books & Documents. Review.
Cited by
-
Effects of environmental enrichment on sensitivity to mu, kappa, and mixed-action opioids in female rats.Physiol Behav. 2008 Jul 5;94(4):563-8. doi: 10.1016/j.physbeh.2008.03.015. Epub 2008 Apr 1. Physiol Behav. 2008. PMID: 18456292 Free PMC article.
-
Activities of mixed NOP and mu-opioid receptor ligands.Br J Pharmacol. 2008 Feb;153(3):609-19. doi: 10.1038/sj.bjp.0707598. Epub 2007 Dec 3. Br J Pharmacol. 2008. PMID: 18059322 Free PMC article.
-
Antinociceptive effects of mixtures of mu opioid receptor agonists and cannabinoid receptor agonists in rats: Impact of drug and fixed-dose ratio.Eur J Pharmacol. 2018 Jan 15;819:217-224. doi: 10.1016/j.ejphar.2017.11.038. Epub 2017 Nov 26. Eur J Pharmacol. 2018. PMID: 29183835 Free PMC article.
-
The effects of amphetamine, butorphanol, and their combination on cocaine self-administration.Behav Brain Res. 2014 Nov 1;274:158-63. doi: 10.1016/j.bbr.2014.08.012. Epub 2014 Aug 12. Behav Brain Res. 2014. PMID: 25127681 Free PMC article.
-
Interactions between opioids and cocaine on locomotor activity in rats: influence of an opioid's relative efficacy at the mu receptor.Psychopharmacology (Berl). 2003 May;167(3):265-73. doi: 10.1007/s00213-003-1388-z. Epub 2003 Apr 1. Psychopharmacology (Berl). 2003. PMID: 12669175
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials